Medicus Pharma (MDCX) Change in Accured Expenses (2024 - 2025)
Medicus Pharma (MDCX) reported Change in Accured Expenses of -$549969.0 for Q4 2025, down 560.26% on a YoY basis from $119492.0 in Q4 2024, and up 42.37% quarter-over-quarter from -$954308.0 in Q3 2025.
Medicus Pharma (MDCX) Change in Accured Expenses (2024 - 2025) Analysis & Trends
Medicus Pharma has reported Change in Accured Expenses for 2 years, with the latest figure at -$549969.0 in Q4 2025.
- For the quarter ending Q4 2025, Change in Accured Expenses fell 560.26% year-over-year to -$549969.0; the trailing twelve-month figure through Dec 2025 stood at -$438802.0 (down 222.56% YoY), and the FY2025 full-year result was -$438802.0, down 222.56% from the prior year.
- Change in Accured Expenses for Q4 2025 stood at -$549969.0, up from -$954308.0 in the prior quarter.
- The five-year high for Change in Accured Expenses was $766272.0 in Q2 2025, with the low at -$954308.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | - |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | -629.00 Mn |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | -1.59 Bn |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | - |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | -75.00 Mn |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | -702.00 Mn |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | -3.50 Bn |
| 10 | Medicus Pharma | 6.05 Mn | 6.15 Mn | - | -549,969.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -549,969.00 |
| Dec 31, 2025 | -549,969.00 |
| Sep 30, 2025 | -954,308.00 |
| Sep 30, 2025 | -954,308.00 |
| Jun 30, 2025 | 766,272.00 |
| Jun 30, 2025 | 766,272.00 |
| Mar 31, 2025 | 299,203.00 |
| Mar 31, 2025 | 299,203.00 |
| Dec 31, 2024 | 119,492.00 |
| Dec 31, 2024 | 119,492.00 |
| Sep 30, 2024 | 23,829.00 |
| Sep 30, 2024 | 23,829.00 |
| Jun 30, 2024 | 224,354.00 |
| Jun 30, 2024 | 224,354.00 |
| Mar 31, 2024 | -9,657.00 |
| Mar 31, 2024 | -9,657.00 |